Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients

Clinical trial NCT06513949 · RECRUITING

Trial details

NCT number: NCT06513949
Sponsor: Implicit Bioscience
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome Adult Respiratory Distress Syndrome Acute Lung Injury Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

Start date: 2026-06-17
Primary completion: 2029-03-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.